Clinical Trial Update: Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating APR-246 in combination with azacitidine for myelodysplastic syndrome with gene mutation and acute myeloid leukemia with gene mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• APR-246 (eprenetapopt)
• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Myelodysplastic Syndrome With Gene Mutation, Acute Myeloid Leukemia With Gene Mutations | Phase 1, Phase 2 | Status: UNKNOWN